Team

  • team

    Heinz-Josef Lenz, M.D

    Professor of Medicine and Associate Director for clinical research and co-leader of the gastrointestinal cancers program at the USC Norris…

    by
  • team

    Per Pfeiffer, MD, PhD

    Professor at the University of Southern Denmark and Senior Consultant at the Department of Oncology at Odense University Hospital in…

    by
  • Pär-Ola Mannefred
    team

    Pär-Ola Mannefred

    Pär-Ola Mannefred has an MBA from the School of Economics in Gothenburg. Contractor and active in own investment activities. Former…

    by
  • team

    Magnus Björsne

    Magnus he has been active in the field of business development at AstraZeneca since 2006. He has also been responsible…

    by
  • Anna Belfrage
    team

    Anna Belfrage

    Anna Belfrage is a graduate economist from Lund University. MBA Other assignments: Board member Note AB, Mycronic AB and Serneke…

    by
  • team

    Robert Marchesani

    Mr Robert Marchesani is currently principal at Proventus Health Solutions, LLC and an adjunct faculty member and executive career mentor…

    by
  • team

    Paula Boultbee

    Paula´s skillset spans global commercialization planning, pre-launch preparation, major launch initiatives for first-in-class agents, and patient advocacy. She has been involved…

    by
  • team

    Alain Herrera

    Dr. Alain Herrera, MD, PhD is an oncologist / hematologist that has contributed directly to the worldwide registration of, among others,…

    by
  • Aram Mangasarian
    team

    Aram Mangasarian

    Aram is CEO and member of the Executive Board of Noxxon Pharma, Germany. He brings over twenty years’ experience in…

    by
  • Ulf Jungnelius
    team

    Ulf Jungnelius

    Ulf has been a director of Isofol since 2010 and has been its clinical and regulatory expert. He has a…

    by